These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37849662)

  • 1. Clinical Peptidomics: Advances in Instrumentation, Analyses, and Applications.
    Li L; Wu J; Lyon CJ; Jiang L; Hu TY
    BME Front; 2023; 4():0019. PubMed ID: 37849662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Peptidomic Biomarkers in Kidney Diseases.
    Sirolli V; Pieroni L; Di Liberato L; Urbani A; Bonomini M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology.
    Amalric A; Bastide A; Attina A; Choquet A; Vialaret J; Lehmann S; David A; Hirtz C
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):1-18. PubMed ID: 34473579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins, Technological Advancement, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2024; 2758():3-47. PubMed ID: 38549006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic-based biomarker discovery for development of next generation diagnostics.
    Khalilpour A; Kilic T; Khalilpour S; Álvarez MM; Yazdi IK
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):475-491. PubMed ID: 28013407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and peptidomics: moving toward precision medicine in urological malignancies.
    Di Meo A; Pasic MD; Yousef GM
    Oncotarget; 2016 Aug; 7(32):52460-52474. PubMed ID: 27119500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
    Zhang F; Chen JY
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research.
    Macklin A; Khan S; Kislinger T
    Clin Proteomics; 2020; 17():17. PubMed ID: 32489335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides in body fluids and tissues as markers of disease.
    Schulte I; Tammen H; Selle H; Schulz-Knappe P
    Expert Rev Mol Diagn; 2005 Mar; 5(2):145-57. PubMed ID: 15833045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidomics analysis of lymphoblastoid cell lines.
    Fogli A; Bulet P
    Methods Mol Biol; 2010; 615():247-57. PubMed ID: 20013214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.
    Levy B; Hu ZI; Cordova KN; Close S; Lee K; Becker D
    Oncologist; 2016 Sep; 21(9):1121-30. PubMed ID: 27388233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of the Third Annual Biomarker World Congress: biomarkers for molecular diagnostics.
    Burczynski ME
    Expert Opin Med Diagn; 2007 Sep; 1(1):147-50. PubMed ID: 23489278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origins, Technological Development, and Applications of Peptidomics.
    Schrader M
    Methods Mol Biol; 2018; 1719():3-39. PubMed ID: 29476501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine for suicidality: from universality to subtypes and personalization.
    Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
    Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.
    Catanese L; Siwy J; Mischak H; Wendt R; Beige J; Rupprecht H
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic approach to biomarker identification and its recent applications.
    He YD
    Cancer Biomark; 2006; 2(3-4):103-33. PubMed ID: 17192065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.